Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entereg for GI recovery after ovarian cancer surgery
NCT01704651Phase 3Completed
- Start
- Jan 2013
- Primary completion
- Aug 2015
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of alvimopan in postoperative ileus (POI). Primary endpoint: Postoperative Length of Hospital Stay at 5 days. Started Jan 2013; status: completed.
02
Drugs
alvimopan
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on NCT01704651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01704651.